Drug Type Unknown |
Synonyms ES-516 |
Target |
Action modulators |
Mechanism TP53RK modulators(TP53 regulating kinase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Preclinical | China | 12 Mar 2026 |





